Journal of Neurology

, Volume 253, Supplement 7, pp vii48–vii53

Parkinson’s disease and fatigue

  • Fumihito Yoshii
  • Hirohide Takahashi
  • Ryuya Kumazawa
  • Satoko Kobori
Article

Abstract

Fatigue is one of the most common symptoms in patients with Parkinson’s disease (PD), and its impact on the quality of life is substantial. However, its cause and treatment are not established. Fatigue in PD has two components, peripheral and central, which may be related to each other, but are more likely independent. Fatigue is partially associated with depression or sleep disorders, but patients with fatigue are not always depressed and do not necessarily have sleep problems. Anti-PD drugs may exacerbate or reduce fatigue. The impact of fatigue in PD is often underestimated by health-care providers.

Key words

Parkinson’s disease fatigue depression sleep disorder QOL 

References

  1. 1.
    Abe K, Takanashi M, Yanagihara T (2000) Fatigue in patients with Parkinson’s disease. Behav Neurol 12:103–106PubMedGoogle Scholar
  2. 2.
    Abe K, Takanashi M, Yanagihara T et al. (2001–2002) Pergolide mesilate may improve fatigue in patients with Parkinson’s disease. Behav Neurol 13:117–121PubMedGoogle Scholar
  3. 3.
    Abudi S, Bar-Tal Y, Ziv L et al. (1997) Parkinson’s disease symptoms—patient’s perception. J Adv Nurs 25:54–59PubMedCrossRefGoogle Scholar
  4. 4.
    Boer AG, Wijker W, Speelman JD et al. (1996) Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 61:70–74PubMedCrossRefGoogle Scholar
  5. 5.
    Brown RG, Dittner A, Findley L et al. (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11:49–55PubMedCrossRefGoogle Scholar
  6. 6.
    Burn DJ (2002) Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson’s disease. Mov Disord 17:445–454PubMedCrossRefGoogle Scholar
  7. 7.
    Cathebras PJ, Robbins JM, Kirmayer LJ et al. (1992) Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Int Med 7:276–286Google Scholar
  8. 8.
    Chalder T, Berelowitz G, Pawlikowska T et al. (1993) Development of a fatigue scale. J Psychosom Res 37:147–153PubMedCrossRefGoogle Scholar
  9. 9.
    Chaudhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179:34–42PubMedCrossRefGoogle Scholar
  10. 10.
    David A, Pelosi A, McDonald E et al. (1990) Tired, weak, or in need of rest: fatigue among general practice attenders. Br Med J 301:1199–1202Google Scholar
  11. 11.
    Davis JM (1995) Central and peripheral factors in fatigue. J Sports Sci 13:S49–S53PubMedGoogle Scholar
  12. 12.
    Davis JM, Bailey SP (1997) Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 29:45–47PubMedGoogle Scholar
  13. 13.
    Dooneief G, Mirabello E, Bell K, et al. 81992) An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch Neurol 49:305–307PubMedGoogle Scholar
  14. 14.
    Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45:33–38PubMedCrossRefGoogle Scholar
  15. 15.
    Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135–138PubMedGoogle Scholar
  16. 16.
    Friedman J, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2108PubMedGoogle Scholar
  17. 17.
    Friedman JH, Friedman H (2001) Fatigue in Parkinson’s disease: a nine-year follow-up. Mov Disord 6:1120–1122CrossRefGoogle Scholar
  18. 18.
    Fulcher KY, White PD (1997) Randomized controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br Med J 314:1647–1652Google Scholar
  19. 19.
    Funkiewiez A, Ardouin C, Krack P et al. (2003) Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Mov Disord 18:524–530PubMedCrossRefGoogle Scholar
  20. 20.
    Garber CE, Friedman JH (2003) Effects of fatigue on physical activity and function in patients with Parkinson’s disease. Neurology 60:1119–1124PubMedGoogle Scholar
  21. 21.
    Gillson G, Richard TL, Smith RB et al. (2002) A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis. Mult Scler 8:30–35PubMedCrossRefGoogle Scholar
  22. 22.
    Herlofson K, Larsen JP (2003) The influence of fatigue on health-related quality of life in patients with Parkinson’s disease. Acta Neurol Scand 107:1–6PubMedCrossRefGoogle Scholar
  23. 23.
    Hilten JJ, Weggeman M, van der Velde EA et al. (1993) Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm (P-D Sect) 5:235–244CrossRefGoogle Scholar
  24. 24.
    Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedCrossRefGoogle Scholar
  25. 25.
    Hwang WJ, Lin TS (2001) Evaluation of fatigue in Parkinson’s disease patients with stimulated single fiber electromyography. Acta Neurol Scand 104:271–274PubMedCrossRefGoogle Scholar
  26. 26.
    Karlsen K, Larsen JP, Tandberg E et al. (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14:237–241PubMedCrossRefGoogle Scholar
  27. 27.
    Kirk J, Douglass R, Nelson E et al. (1990) Chief complaint of fatigue: a prospective study. J Fam Practice 30:33–39Google Scholar
  28. 28.
    Kroenke K, Wood DR, Mangelsdorff AD et al. (1988) Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 260:929–934PubMedCrossRefGoogle Scholar
  29. 29.
    Krupp LB, LaRocca NG, Muir-Nash J et al. (1989) The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMedGoogle Scholar
  30. 30.
    Krupp LB, Pollina DA (1996) Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 9:456–460PubMedCrossRefGoogle Scholar
  31. 31.
    Levi S, Cox M, Lugon M et al. (1990) Increased energy expenditure in Parkinson’s disease. Br Med J 301:1256–1257CrossRefGoogle Scholar
  32. 32.
    Loge JH, Ekeberg O, Kaasa S (1998) Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 45:53–65PubMedCrossRefGoogle Scholar
  33. 33.
    Lou JS, Benice T, Kearns G et al. (2003) Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson’s disease. Clin Neurophysiol 114:930–937PubMedCrossRefGoogle Scholar
  34. 34.
    Lou JS, Kearns G, Oken B et al. (2001) Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov Disord 16:190–196PubMedCrossRefGoogle Scholar
  35. 35.
    Marek T, Noworol G, Karwowski W (1998) Mental fatigue at work and pain perception. Work Stress 2:133–137Google Scholar
  36. 36.
    Markus HS, Cox M, Tomkins AM (1992) Raised resting energy expenditure in Parkinson’s disease and its relationship to muscle rigidity. Clin Sci 83:199–204PubMedGoogle Scholar
  37. 37.
    Merkies IS, Schmitz PI, Samijn JP et al. (1999) Fatigue in immune-mediated polyneuropathies. Europian Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648–1654PubMedGoogle Scholar
  38. 38.
    Mock V, Atkinson A, Barsevick A et al. (2000) NCCN practice guidelines for cancer-related fatigue. Oncology 14:151–161PubMedGoogle Scholar
  39. 39.
    Mostert S, Kesselring J (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 8:161–168PubMedCrossRefGoogle Scholar
  40. 40.
    Peto V, Jenkinson C, Fitzpatrick R et al. (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248PubMedCrossRefGoogle Scholar
  41. 41.
    Pogarell O, Gasser T, van Hilen JJ et al. (2002) Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomized, double blind, placebo controlled multicentre study. J Neurol Neurosurg Psychiatry 72:713–720PubMedCrossRefGoogle Scholar
  42. 42.
    Portenoy RK, Itri LM (1999) Cancerrelated fatigue: guidelines for evaluation and management. The Oncologist 4:1–10PubMedGoogle Scholar
  43. 43.
    Robb-Nicholson LC, Daltroy L, Eaton H et al. (1989) Effect of aerobic conditioning in lupus fatigue: a pilot study. Br J Rheumatol 28:500–505PubMedGoogle Scholar
  44. 44.
    Roelcke U, Kappos L, Lechner-Scott J et al. (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566–1571PubMedGoogle Scholar
  45. 45.
    Rossini PM, Pasqualetti P, Pozzilli C et al. (2001) Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Multi Scler 7:354–358CrossRefGoogle Scholar
  46. 46.
    Schenkman M, Wei Zhu C, Cutson TM et al. (2001) Longitudinal evaluation of economic and physical impact of Parkinson’s disease. Parkinsonism Relat Disord 8:41–50PubMedCrossRefGoogle Scholar
  47. 47.
    Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312PubMedCrossRefGoogle Scholar
  48. 48.
    Schrag A, Jahanshahi M, Quinn NP (2001) What contributes to depression in Parkinson’s disease? Psychol Med 31:65–73PubMedCrossRefGoogle Scholar
  49. 49.
    Schwab RS, England AC, Peterson C (1959) Akinesia in Parkinson’s disease. Neurology 9:65–72PubMedGoogle Scholar
  50. 50.
    Schwartz A (1998) The Schwartz cancer fatigue scale: testing reliability and validity. Oncol Nurs Forum 25:711–717PubMedGoogle Scholar
  51. 51.
    Schwartz JE, Jandorf L, Krupp LB (1993) The measurement of fatigue: a new instrument. J Psychosom Res 37:753–762PubMedCrossRefGoogle Scholar
  52. 52.
    Shulman LM, Taback RL, Bean J et al. (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 16:507–510PubMedCrossRefGoogle Scholar
  53. 53.
    Smets EM, Garssen B, Bonke B et al. (1995) The Multidimensional Fatigue Inventry (MFI) psychosomatic qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRefGoogle Scholar
  54. 54.
    Swain MG (2000) Fatigue in chronic disease. Clin Sci 99:1–8PubMedCrossRefGoogle Scholar
  55. 55.
    Tandberg E, Larsen JP, Aarsland D et al. (1996) The occurrence of depression in Parkinson’s disease. A community-based study. Arch Neurol 53:175–179PubMedGoogle Scholar
  56. 56.
    Taus C, Giuliani G, Pucci E et al. (2003) Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2:CD002818PubMedGoogle Scholar
  57. 57.
    Tavio M, Milan I, Tirelli U (2002) Cancer-related fatigue (review). Int J Oncol 21:1093–1099PubMedGoogle Scholar
  58. 58.
    Tolson D, Fleming V, Schartau E (2002) Coping with menstruation: understanding the needs of woman with Parkinson’s disease. J Adv Nurs 40:513–521PubMedCrossRefGoogle Scholar
  59. 59.
    Vercoulen JH, Swanink CM, Galama JM et al. (1998) The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 45:507–517PubMedCrossRefGoogle Scholar
  60. 60.
    Wang B, Gladman DD, Urowitz MB (1998) Fatigue in lupus is not correlated with disease activity. J Rheumatol 25:892–895PubMedGoogle Scholar
  61. 61.
    Weinshenker BG, Penman M, Bass B et al. (1992) A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42:1468–1471PubMedGoogle Scholar
  62. 62.
    Ziv I, Avraham M, Michaelov Y et al. (1998) Enhanced fatigue during motor performance in patients with Parkinson’s disease. Neurology 51:1583–1586PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  • Fumihito Yoshii
    • 1
  • Hirohide Takahashi
    • 1
  • Ryuya Kumazawa
    • 1
  • Satoko Kobori
    • 1
  1. 1.Department of NeurologyTokai University School of MedicineKanagawa 259-1193Japan

Personalised recommendations